Exact Sciences will acquire Ashion Analytics, a genetic sequencing lab based in Phoenix, from the Translational Genomics Research Institute (TGen) to support the ongoing development of precision oncology diagnostics.
Ashion has developed GEM ExTra, a comprehensive genomic cancer test, and provides whole exome, matched germline and transcriptome sequencing capabilities and will help Exact develop tests for the TARDIS patient-specific,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?